Phio Pharmaceuticals Chairman, President and CEO Robert J. Bitterman Reports $20,500 Common Share Acquisition

• Phio Pharmaceuticals Chairman, President and CEO Robert J. Bitterman purchased 25,000 shares of common stock at $0.82 each.
• His direct beneficial ownership rose to 789,871 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008469), on November 10, 2026, and is solely responsible for the information contained therein.